Impact of the COVID-19 Pandemic on Inpatient Antibiotic Use in the United States, January 2019 Through July 2022.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 37536269.
- Also identified by DOI 10.1093/cid/ciad453 and PMC identifier 11629484.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Antimicrobial use data reported to the National Healthcare Safety Network's Antimicrobial Use and Resistance Module between January 2019 and July 2022 were analyzed to assess the impact of the COVID-19 pandemic on inpatient antimicrobial use.
Medical subject headings
- COVID-19
- Anti-Infective Agents